188 related articles for article (PubMed ID: 16048960)
1. Six groups of the OXY beta-Lactamase evolved over millions of years in Klebsiella oxytoca.
Fevre C; Jbel M; Passet V; Weill FX; Grimont PA; Brisse S
Antimicrob Agents Chemother; 2005 Aug; 49(8):3453-62. PubMed ID: 16048960
[TBL] [Abstract][Full Text] [Related]
2. Recognition of two genetic groups in the Klebsiella oxytoca taxon on the basis of chromosomal beta-lactamase and housekeeping gene sequences as well as ERIC-1 R PCR typing.
Granier SA; Plaisance L; Leflon-Guibout V; Lagier E; Morand S; Goldstein FW; Nicolas-Chanoine MH
Int J Syst Evol Microbiol; 2003 May; 53(Pt 3):661-668. PubMed ID: 12807183
[TBL] [Abstract][Full Text] [Related]
3. New Klebsiella oxytoca beta-lactamase genes bla(OXY-3) and bla(OXY-4) and a third genetic group of K oxytoca based on bla(OXY-3).
Granier SA; Leflon-Guibout V; Goldstein FW; Nicolas-Chanoine MH
Antimicrob Agents Chemother; 2003 Sep; 47(9):2922-8. PubMed ID: 12936995
[TBL] [Abstract][Full Text] [Related]
4. Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins.
Izdebski R; Fiett J; Urbanowicz P; Baraniak A; Derde LP; Bonten MJ; Carmeli Y; Goossens H; Hryniewicz W; Brun-Buisson C; Brisse S; Gniadkowski M; ;
J Antimicrob Chemother; 2015 Dec; 70(12):3230-7. PubMed ID: 26318191
[TBL] [Abstract][Full Text] [Related]
5. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
[TBL] [Abstract][Full Text] [Related]
6. Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.
Chen LR; Zhou HW; Cai JC; Zhang R; Chen GX
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):163-7. PubMed ID: 19748427
[TBL] [Abstract][Full Text] [Related]
7. OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity.
Nijhuis RH; Oueslati S; Zhou K; Bosboom RW; Rossen JW; Naas T
J Antimicrob Chemother; 2015 May; 70(5):1429-33. PubMed ID: 25630648
[TBL] [Abstract][Full Text] [Related]
8. Spread of plasmids containing the bla(VIM-1) and bla(CTX-M) genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates.
Miró E; Segura C; Navarro F; Sorlí L; Coll P; Horcajada JP; Alvarez-Lerma F; Salvadó M
J Antimicrob Chemother; 2010 Apr; 65(4):661-5. PubMed ID: 20089541
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum beta-lactamases and strains with extended-spectrum activity of the chromosomal beta-lactamase.
Decré D; Burghoffer B; Gautier V; Petit JC; Arlet G
J Antimicrob Chemother; 2004 Nov; 54(5):881-8. PubMed ID: 15472005
[TBL] [Abstract][Full Text] [Related]
10. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
Oksüz L; Gürler N
Mikrobiyol Bul; 2009 Apr; 43(2):183-94. PubMed ID: 19621602
[TBL] [Abstract][Full Text] [Related]
11. In vivo selection of a chromosomally encoded beta-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca.
Mammeri H; Poirel L; Nordmann P
Antimicrob Agents Chemother; 2003 Dec; 47(12):3739-42. PubMed ID: 14638475
[TBL] [Abstract][Full Text] [Related]
12. Identification of clinical isolates of indole-positive Klebsiella spp., including Klebsiella planticola, and a genetic and molecular analysis of their beta-lactamases.
Liu Y; Mee BJ; Mulgrave L
J Clin Microbiol; 1997 Sep; 35(9):2365-9. PubMed ID: 9276417
[TBL] [Abstract][Full Text] [Related]
13. First report of a novel extended-spectrum beta-lactamase KOXY-2 producing Klebsiella oxytoca that hydrolyses cefotaxime and ceftazidime.
Younes A; Hamouda A; Amyes SG
J Chemother; 2011 Jun; 23(3):127-30. PubMed ID: 21742579
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.
Yigit H; Queenan AM; Rasheed JK; Biddle JW; Domenech-Sanchez A; Alberti S; Bush K; Tenover FC
Antimicrob Agents Chemother; 2003 Dec; 47(12):3881-9. PubMed ID: 14638498
[TBL] [Abstract][Full Text] [Related]
16. Variability of chromosomally encoded beta-lactamases from Klebsiella oxytoca.
Fournier B; Roy PH
Antimicrob Agents Chemother; 1997 Aug; 41(8):1641-8. PubMed ID: 9257734
[TBL] [Abstract][Full Text] [Related]
17. [Combination of bla(VIM-1) and qnrS2 on the same plasmid in Klebsiella oxytoca and Klebsiella pneumoniae isolates in Seville].
Rodríguez-Martínez JM; Conejo MC; Díaz de Alba P; López-Cerero L; Fernandez-Echauri P; Pascual A
Enferm Infecc Microbiol Clin; 2012 May; 30(5):246-8. PubMed ID: 22257559
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016-2017.
Pérez-Vazquez M; Oteo-Iglesias J; Sola-Campoy PJ; Carrizo-Manzoni H; Bautista V; Lara N; Aracil B; Alhambra A; Martínez-Martínez L; Campos J;
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936106
[TBL] [Abstract][Full Text] [Related]
19. Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals.
Williamson DA; Sidjabat HE; Freeman JT; Roberts SA; Silvey A; Woodhouse R; Mowat E; Dyet K; Paterson DL; Blackmore T; Burns A; Heffernan H
Int J Antimicrob Agents; 2012 Jun; 39(6):529-33. PubMed ID: 22526013
[TBL] [Abstract][Full Text] [Related]
20. Identification of a blaVIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary.
Kristóf K; Tóth A; Damjanova I; Jánvári L; Konkoly-Thege M; Kocsis B; Koncan R; Cornaglia G; Szego E; Nagy K; Szabó D
J Antimicrob Chemother; 2010 Jun; 65(6):1303-5. PubMed ID: 20410063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
